Ornit Chiba-Falek

Professor and Division Chief

Duke University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ornit Chiba-Falek is a Professor and Division Chief at Duke University in the United States. Her research focuses on gene editing therapeutics for neurodegenerative diseases, including the development of AAV-delivered platforms and their epigenomic implications. She has authored multiple articles examining the genetic and molecular underpinnings of conditions such as Alzheimer's disease and Parkinson's disease, with an emphasis on precision medicine and therapeutic targets.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Michael W. Lutz

Duke University School of Medicine

UNITED STATES

View details

Allison Ashley-Koch

Professor

Duke University Medical Center

UNITED STATES

View details

Douglas Williamson

Professor

Duke University Health System

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ornit Chiba-Falek

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Trends and challenges of AAV-delivered gene editing therapeutics for unmet needs in CNS disorders: Implications for neurodegenerative disease

Comparative mapping of single‐cell transcriptomic landscapes in neurodegenerative diseases

The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders

Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies

Integrative single-nucleus multi-omics analysis prioritizes candidate cis and trans regulatory networks and their target genes in Alzheimer’s disease brains

Differential Gene Expression and DNA Methylation in the Risk of Depression in LOAD Patients

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s

Shared genetic etiology underlying late‐onset Alzheimer's disease and posttraumatic stress syndrome

The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson’s disease SNCA mutations

Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders

Collaborators (3)

Michael W. Lutz

Allison Ashley-Koch

Douglas Williamson

Make your next move.